Jeisys Medical, a leader in non-invasive aesthetic devices, has secured investment from NiXEN and ARCHIMED to support its international growth and expansion strategy.

Target Information

Jeisys Medical, established in 2001 in Seoul, is a global leader in non-invasive aesthetic medical devices, specializing in skin care solutions known as Energy-Based Devices (EBD). These innovative technologies are designed to rejuvenate skin, treat scars, dissolve fat cells, remove hair, and facilitate body sculpting through various energy forms, including lasers, intense pulsed light, radiofrequency, and ultrasound. By utilizing EBD techniques, Jeisys significantly reduces the need for needles, thus minimizing discomfort and downtime for patients.

Over the past three years, Jeisys Medical has demonstrated remarkable growth, with an annual revenue increase of 44%, culminating in a revenue of 143 billion KRW (€97 million) and an EBITDA of 41 billion KRW (€28 million). The company has emerged as the leading supplier of EBD in Japan, which is recognized as the most advanced market globally for aesthetic medicine.

Industry Overview in South Korea

The aesthetic medical device industry in South Korea is rapidly evolving, driven by increasing consumer demand for non-invasive cosmetic procedures. This growing trend is supported by a highly competitive market landscape, characterized by con